US EditionPublished • loading... • Updated
Apogee Therapeutics, Inc. Announces Proposed Underwritten Public Offering
Summary by Enid News & Eagle
2 Articles
2 Articles
Hastings TribuneReposted by 
Enid News & Eagle
Enid News & EagleApogee Therapeutics, Inc. Announces Proposed Underwritten Public Offering
SAN FRANCISCO and BOSTON, Oct. 08, 2025 (GLOBE NEWSWIRE) -- Apogee Therapeutics, Inc. (Nasdaq: APGE), a clinical-stage biotechnology company advancing optimized, novel biologics with potential for best-in-class profiles in the largest inflammatory and immunology (I&I) markets, today announced that it…
Coverage Details
Total News Sources2
Leaning Left1Leaning Right0Center1Last UpdatedBias Distribution50% Left, 50% Center
Bias Distribution
- 50% of the sources lean Left, 50% of the sources are Center
50% Center
L 50%
C 50%
Factuality
To view factuality data please Upgrade to Premium
